Carl Zeiss Meditec (ETR:AFX) PT Set at €89.00 by Deutsche Bank

Deutsche Bank set a €89.00 ($103.49) target price on Carl Zeiss Meditec (ETR:AFX) in a research report report published on Monday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Several other equities analysts also recently weighed in on AFX. HSBC set a €84.00 ($97.67) target price on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Monday, June 3rd. Nord/LB set a €92.00 ($106.98) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Wednesday, May 8th. Berenberg Bank set a €93.00 ($108.14) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Wednesday, July 17th. Independent Research set a €88.00 ($102.33) price objective on Carl Zeiss Meditec and gave the company a sell rating in a research report on Wednesday, July 17th. Finally, Hauck & Aufhaeuser set a €92.50 ($107.56) price objective on Carl Zeiss Meditec and gave the company a buy rating in a research report on Monday, April 15th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. Carl Zeiss Meditec presently has an average rating of Hold and a consensus target price of €84.06 ($97.75).

ETR AFX opened at €97.90 ($113.84) on Monday. The company has a market cap of $8.76 billion and a P/E ratio of 68.27. The company has a debt-to-equity ratio of 4.55, a quick ratio of 3.09 and a current ratio of 4.11. The business’s 50 day moving average price is €93.49 and its 200-day moving average price is €84.73. Carl Zeiss Meditec has a fifty-two week low of €60.25 ($70.06) and a fifty-two week high of €104.30 ($121.28).

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

See Also: What are earnings reports?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.